RNA-seq does not quantitatively assign PD-L1 expression levels to specific cell types, although the clinical value of making this distinction using current IHC techniques also appears to be variable, with NSCLC tumors that harbor one and not the other potentially representing different patient subgroups [15,25,34]. Here, CD274 is linked to non-small cell lung carcinoma.